Medindia

X

Novartis Japan Will Face Penalty Over Failing to Report Drug Side Effects

by Dr. Trupti Shirole on  February 5, 2015 at 12:56 AM Medico Legal News   - G J E 4
Japanese health authorities will soon make a decision on a possible penalty against the local unit of Swiss pharmaceutical giant Novartis for failing to report drug side effects in more than 3,000 cases that may have been caused by about two dozen company drugs.
 Novartis Japan Will Face Penalty Over Failing to Report Drug Side Effects
Novartis Japan Will Face Penalty Over Failing to Report Drug Side Effects
Advertisement

The regulators would slap a 15-day suspension order on the firm, meaning the company could not sell most of its drugs during the two-week period. A spokesman said, "We haven't decided anything yet, but it should be announced soon."

Advertisement
The Swiss firm's Japanese unit declined to comment on Wednesday. However, the health ministry said that a decision was imminent.

Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All